← Leaderboards
Shannon Elizabeth Boye
University Of Florida
$7,910,294
Attributed
$9,000,040
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,000,040 · 2
By mechanism
R01$9,000,040 · 2
Top collaborators
- Paul Douglas Gamlin4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Susan Lynn Semple-Rowland$2,994,898
- William W Hauswirth$34,023,360
- Jijing Pang$805,855
- Kaitlyn Rose Calabro$57,991
Others in their field
Top investigators on “Inherited”
- Richard A Gibbs · Baylor College Of Medicine$245,563,927
- Randall J Bateman · Washington University$163,452,954
- Eric Martin McDade · Washington University$96,219,353
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$95,176,138
- David Heimbrook · Leidos Biomedical Research, Inc.$80,380,094
- Stacey Gabriel · Massachusetts Institute Of Technology$78,099,411
Research focus
InheritedEngineeringPeripheralPrimatesVariantCapsidRetinaRetinal DiseasesDependovirusPhotoreceptorsVectorGenesConeVisual AcuityDoseAdeno-Associated Viral VectorVisionSiteBaseClinical TrialsCellsGene TherapyLeber&AposLibraries
Grant awards (17)
Engineering AAV for safe and efficient gene delivery to the human retina$637,990
R01 · FY2025 · EY · contact PI
Engineering AAV for safe and efficient gene delivery to the human retina$651,115
R01 · FY2024 · EY · contact PI
Engineering AAV for safe and efficient gene delivery to the human retina$673,592
R01 · FY2023 · EY · contact PI
Engineering AAV for safe and efficient gene delivery to the human retina$653,385
R01 · FY2022 · EY · contact PI
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY$521,101
R01 · FY2022 · EY · contact PI
Engineering AAV for safe and efficient gene delivery to the human retina$687,914
R01 · FY2021 · EY · contact PI
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY$536,347
R01 · FY2021 · EY · contact PI
Engineering AAV for safe and efficient gene delivery to the human retina$694,739
R01 · FY2020 · EY · contact PI
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY$554,460
R01 · FY2020 · EY · contact PI
Engineering AAV for safe and efficient gene delivery to the human retina$704,894
R01 · FY2019 · EY · contact PI
DEVELOPMENT OF AAV-CRISPR/CAS9-BASED THERAPIES FOR CONE ROD DYSTROPHY$567,585
R01 · FY2019 · EY · contact PI
Developing efficient AAV vectors for photoreceptor targeting via the vitreous$240,782
R01 · FY2018 · EY · contact PI
Developing efficient AAV vectors for photoreceptor targeting via the vitreous$472,914
R01 · FY2017 · EY · contact PI
Developing efficient AAV vectors for photoreceptor targeting via the vitreous$485,794
R01 · FY2016 · EY · contact PI
Developing efficient AAV vectors for photoreceptor targeting via the vitreous$486,143
R01 · FY2015 · EY · contact PI
Developing efficient AAV vectors for photoreceptor targeting via the vitreous$56,701
R01 · FY2015 · EY · contact PI
Developing efficient AAV vectors for photoreceptor targeting via the vitreous$374,584
R01 · FY2014 · EY · contact PI